A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy

Psycho-Oncology

Volumn 9, Issue 6, 2000, Pages 486-495

  Hallowell, N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ADULT; ARTICLE; AWARENESS; CLINICAL ARTICLE; CONVALESCENCE; DOCTOR PATIENT RELATION; EMOTION; FEMALE; GENETIC COUNSELING; GENETIC RISK; GOOD CLINICAL PRACTICE; HEADACHE; HEALTH CARE COST; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; INFORMED CONSENT; MEDICAL DECISION MAKING; MENOPAUSE; OVARIECTOMY; OVARY CANCER; OVARY FUNCTION; PATIENT EDUCATION; PREMENOPAUSE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; RISK MANAGEMENT;

ADULT; COST-BENEFIT ANALYSIS; DECISION MAKING; EMOTIONS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PREMENOPAUSE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034529238     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1611(200011/12)9:6<486::AID-PON478>3.0.CO;2-Y     Document Type: Article

References (36)

1. Age at onset for familial epithelial ovarian cancer
2. Ultrasound screening for women at risk of ovarian cancer
3. Written information needs of women who are recalled for further investigation of breast screening: Results of a multicentre study
4. Mutation in the DNA mismatch repair gene homologue hMLH1 is associate with hereditary non-polyposis colon cancer
5. Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2
6. The dynamics of change: Cancer patients' preferences for information, involvement and support
7. Sharing decisions with patients: Is the information good enough?
8. Screening for ovarian cancer: Hopeful and wishful thinking
9. Ovarian ablation in early breast cancer: Overview of randomised trials
10. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer
11. Ovarian cancer family and prophylactic choices
12. No news is not good news: Information preferences of patients with cancer
13. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
14. Communicating information to patients about medicine
15. The value of written summaries of genetic consultations
16. Comparison of oral, written and audio-visually prepared information as preparation for intravenous pyelography
17. Should women with familial ovarian cancer undergo prophylactic oophorectomy?
18. Mutations of a MutS homolog in hereditary nonpolyposis colorectal cancer
19. Cancer patients' information needs and information seeking behaviour: In depth interview study
20. Prophylactic oophorectomy
21. Information needs of cancer patients in the west of Scotland: A cross sectiional survey of patients' views
22. A strong candidate for the breast ovarian cancer susceptibility gene BRCA1
23. Consensus conference statement ovarian cancer: Screening, treatment, and follow-up
24. A qualitative evaluation of the experience of surgery after false positive results in screening for familial ovarian cancer
25. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry
26. Reaching the parts that other methods cannot reach: An introduction to qualitative methods in health and health services research
27. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
28. Decision analysis - Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations
29. Contribution of BRCA1 mutations to ovarian cancer
30. Intra-abdominal carcinornatosis after prophylactic oophorectomy in ovarian-cancer-prone families
31. Familial ovarian cancer
32. Serous carcinoma of the peritoneum after oophorectomy
33. Prevalence and contribution of BRCA1 mutations in breast and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer
34. Localisation of a breast cancer susceptibility gene (BRCA2) to chromosome 13q by linkage analysis